RENBP and atherosclerosis: Pathway enrichment revealed BPA’s coordinated activation of endocrine-disrupting pathways (AGE-RAGE, TNF signaling) and metabolic cascades, with the lipid and atherosclerosis pathway emerging as a novel contributor wherein BPA exacerbates obesity comorbidities through oxidative stress induction and lipid metabolism dysregulation.